Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Discovery | 19 | 2023 | 1068 | 2.970 |
Why?
|
Molecular Probes | 10 | 2023 | 309 | 2.830 |
Why?
|
Endoribonucleases | 8 | 2023 | 231 | 2.600 |
Why?
|
Drug Design | 16 | 2017 | 1046 | 2.040 |
Why?
|
Muscarinic Antagonists | 5 | 2015 | 136 | 1.820 |
Why?
|
Sulfinic Acids | 6 | 2019 | 14 | 1.640 |
Why?
|
Small Molecule Libraries | 8 | 2024 | 742 | 1.480 |
Why?
|
Proteins | 9 | 2023 | 6011 | 1.410 |
Why?
|
Fluorides | 2 | 2023 | 134 | 1.360 |
Why?
|
Reverse Transcriptase Inhibitors | 6 | 2011 | 622 | 1.290 |
Why?
|
Quinazolines | 5 | 2017 | 1373 | 1.190 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 3 | 2015 | 110 | 1.180 |
Why?
|
Click Chemistry | 5 | 2019 | 101 | 1.140 |
Why?
|
Enzyme Inhibitors | 7 | 2019 | 3724 | 1.030 |
Why?
|
Ubiquitin-Protein Ligases | 4 | 2023 | 1903 | 1.010 |
Why?
|
Proteome | 5 | 2023 | 1891 | 0.980 |
Why?
|
Bronchodilator Agents | 3 | 2015 | 518 | 0.970 |
Why?
|
Molecular Targeted Therapy | 6 | 2020 | 2830 | 0.960 |
Why?
|
Protein Kinase Inhibitors | 9 | 2023 | 5707 | 0.950 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2015 | 252 | 0.830 |
Why?
|
Patents as Topic | 2 | 2015 | 111 | 0.800 |
Why?
|
Tyrosine | 3 | 2016 | 1427 | 0.780 |
Why?
|
Drug Evaluation, Preclinical | 4 | 2019 | 1339 | 0.780 |
Why?
|
Structure-Activity Relationship | 15 | 2020 | 3056 | 0.770 |
Why?
|
Cysteine | 5 | 2023 | 897 | 0.760 |
Why?
|
Imidazoles | 5 | 2011 | 1169 | 0.730 |
Why?
|
Chemistry, Pharmaceutical | 5 | 2017 | 275 | 0.710 |
Why?
|
Molecular Structure | 15 | 2019 | 1885 | 0.690 |
Why?
|
Janus Kinase 3 | 2 | 2017 | 76 | 0.690 |
Why?
|
Down-Regulation | 2 | 2017 | 2941 | 0.680 |
Why?
|
Photoaffinity Labels | 2 | 2021 | 85 | 0.680 |
Why?
|
Proteomics | 6 | 2019 | 3913 | 0.670 |
Why?
|
Polymers | 2 | 2022 | 1632 | 0.660 |
Why?
|
Cell Membrane Permeability | 4 | 2016 | 573 | 0.650 |
Why?
|
CREB-Binding Protein | 2 | 2017 | 147 | 0.640 |
Why?
|
Sulfuric Acids | 1 | 2017 | 36 | 0.590 |
Why?
|
Biological Assay | 1 | 2020 | 628 | 0.580 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2015 | 3253 | 0.570 |
Why?
|
HIV Reverse Transcriptase | 4 | 2011 | 214 | 0.570 |
Why?
|
Protein Processing, Post-Translational | 3 | 2020 | 1966 | 0.560 |
Why?
|
Muscular Atrophy, Spinal | 2 | 2017 | 261 | 0.550 |
Why?
|
RNA Cap-Binding Proteins | 1 | 2016 | 15 | 0.550 |
Why?
|
Phosphotransferases | 1 | 2017 | 302 | 0.550 |
Why?
|
Urea | 2 | 2008 | 448 | 0.520 |
Why?
|
Microsomes, Liver | 4 | 2017 | 174 | 0.520 |
Why?
|
Protein Kinases | 3 | 2018 | 1611 | 0.520 |
Why?
|
Receptor, Muscarinic M3 | 2 | 2015 | 37 | 0.510 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 664 | 0.500 |
Why?
|
Models, Molecular | 13 | 2019 | 5404 | 0.470 |
Why?
|
Fluorescent Dyes | 2 | 2016 | 1933 | 0.460 |
Why?
|
Lysine | 2 | 2018 | 1000 | 0.460 |
Why?
|
Vaccines, Synthetic | 2 | 2015 | 622 | 0.460 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1320 | 0.460 |
Why?
|
Lysosomes | 1 | 2020 | 940 | 0.460 |
Why?
|
Pyrroles | 2 | 2017 | 1126 | 0.440 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2016 | 423 | 0.440 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 560 | 0.440 |
Why?
|
Molecular Conformation | 5 | 2018 | 540 | 0.430 |
Why?
|
Serine | 1 | 2017 | 831 | 0.430 |
Why?
|
Temperature | 3 | 2016 | 2235 | 0.420 |
Why?
|
Pyrimidines | 4 | 2019 | 3050 | 0.420 |
Why?
|
Sulfur Compounds | 3 | 2009 | 32 | 0.420 |
Why?
|
Crystallography, X-Ray | 6 | 2017 | 1952 | 0.420 |
Why?
|
Reactive Nitrogen Species | 1 | 2012 | 35 | 0.410 |
Why?
|
Receptors, Glucagon | 1 | 2013 | 90 | 0.410 |
Why?
|
Drug Industry | 2 | 2016 | 793 | 0.410 |
Why?
|
Oligonucleotides | 2 | 2012 | 563 | 0.410 |
Why?
|
Biology | 1 | 2014 | 292 | 0.400 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 162 | 0.400 |
Why?
|
Administration, Inhalation | 3 | 2011 | 1169 | 0.390 |
Why?
|
Amino Acids | 2 | 2021 | 1716 | 0.370 |
Why?
|
Thermodynamics | 2 | 2009 | 591 | 0.370 |
Why?
|
Stereoisomerism | 6 | 2016 | 612 | 0.350 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2011 | 187 | 0.350 |
Why?
|
Carbonic Anhydrase II | 1 | 2009 | 21 | 0.340 |
Why?
|
Pharmaceutical Preparations | 2 | 2016 | 1088 | 0.340 |
Why?
|
Triazoles | 1 | 2015 | 904 | 0.340 |
Why?
|
Adrenergic beta-Agonists | 1 | 2011 | 347 | 0.340 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2013 | 374 | 0.340 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2009 | 92 | 0.330 |
Why?
|
Survival of Motor Neuron 2 Protein | 3 | 2017 | 49 | 0.310 |
Why?
|
Pyrazoles | 4 | 2017 | 2029 | 0.310 |
Why?
|
Molecular Imaging | 1 | 2015 | 826 | 0.310 |
Why?
|
Rare Diseases | 1 | 2014 | 630 | 0.310 |
Why?
|
Amides | 1 | 2011 | 452 | 0.300 |
Why?
|
Phenylenediamines | 1 | 2008 | 89 | 0.300 |
Why?
|
RNA, Messenger | 4 | 2017 | 12809 | 0.300 |
Why?
|
Fluorine | 1 | 2007 | 83 | 0.290 |
Why?
|
Ethers | 1 | 2007 | 73 | 0.290 |
Why?
|
Eukaryotic Cells | 2 | 2020 | 192 | 0.290 |
Why?
|
Indazoles | 1 | 2009 | 306 | 0.280 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2007 | 223 | 0.280 |
Why?
|
Humans | 63 | 2024 | 768887 | 0.280 |
Why?
|
Nitriles | 1 | 2011 | 990 | 0.250 |
Why?
|
Mass Spectrometry | 5 | 2019 | 2204 | 0.250 |
Why?
|
Binding Sites | 8 | 2021 | 6023 | 0.250 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2238 | 0.240 |
Why?
|
Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2024 | 23 | 0.240 |
Why?
|
Leukocytes, Mononuclear | 3 | 2017 | 1855 | 0.240 |
Why?
|
Cells, Cultured | 9 | 2019 | 19023 | 0.240 |
Why?
|
Mental Retardation, X-Linked | 1 | 2024 | 42 | 0.230 |
Why?
|
Validation Studies as Topic | 2 | 2016 | 162 | 0.230 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 1813 | 0.220 |
Why?
|
Cell Line | 5 | 2022 | 15603 | 0.220 |
Why?
|
Antiviral Agents | 3 | 2016 | 3069 | 0.220 |
Why?
|
Catalytic Domain | 2 | 2017 | 699 | 0.220 |
Why?
|
Anti-HIV Agents | 3 | 2009 | 4576 | 0.220 |
Why?
|
Bronchoconstriction | 2 | 2015 | 141 | 0.210 |
Why?
|
Animals | 25 | 2024 | 169408 | 0.210 |
Why?
|
Lipids | 3 | 2012 | 3345 | 0.210 |
Why?
|
Sulfur | 1 | 2023 | 158 | 0.210 |
Why?
|
Glycoconjugates | 1 | 2002 | 88 | 0.200 |
Why?
|
Sulfhydryl Compounds | 2 | 2015 | 296 | 0.200 |
Why?
|
Adenosine Triphosphate | 3 | 2017 | 2003 | 0.200 |
Why?
|
Chromatography, Affinity | 1 | 2023 | 525 | 0.200 |
Why?
|
Glycolipids | 1 | 2002 | 205 | 0.190 |
Why?
|
Diazonium Compounds | 1 | 2021 | 17 | 0.190 |
Why?
|
HEK293 Cells | 4 | 2024 | 4291 | 0.190 |
Why?
|
Polymerization | 1 | 2022 | 155 | 0.190 |
Why?
|
Hemoglobin A | 1 | 2020 | 84 | 0.180 |
Why?
|
Periodicals as Topic | 1 | 2012 | 1470 | 0.180 |
Why?
|
Protein Binding | 6 | 2017 | 9344 | 0.180 |
Why?
|
Hemoglobin, Sickle | 1 | 2020 | 113 | 0.180 |
Why?
|
Serum Albumin, Bovine | 2 | 2011 | 320 | 0.170 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13699 | 0.170 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3110 | 0.170 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2008 | 2203 | 0.170 |
Why?
|
Ubiquitination | 2 | 2022 | 1010 | 0.170 |
Why?
|
Guinea Pigs | 2 | 2011 | 1309 | 0.160 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10778 | 0.160 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13593 | 0.150 |
Why?
|
Diphosphonates | 1 | 2002 | 634 | 0.150 |
Why?
|
Isothiocyanates | 1 | 2017 | 48 | 0.140 |
Why?
|
Enzyme Stability | 1 | 2017 | 219 | 0.140 |
Why?
|
Myotonic Dystrophy | 1 | 2017 | 80 | 0.140 |
Why?
|
E1A-Associated p300 Protein | 1 | 2017 | 125 | 0.140 |
Why?
|
Benzbromarone | 1 | 2016 | 7 | 0.140 |
Why?
|
Models, Chemical | 2 | 2008 | 611 | 0.130 |
Why?
|
Janus Kinases | 1 | 2017 | 253 | 0.130 |
Why?
|
Prokaryotic Cells | 1 | 2016 | 53 | 0.130 |
Why?
|
Chromans | 1 | 2016 | 116 | 0.130 |
Why?
|
Tritium | 1 | 2016 | 707 | 0.130 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2016 | 118 | 0.130 |
Why?
|
Ipratropium | 1 | 2015 | 19 | 0.130 |
Why?
|
Shock, Septic | 1 | 2002 | 774 | 0.130 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2016 | 108 | 0.130 |
Why?
|
Inhibitory Concentration 50 | 3 | 2017 | 466 | 0.130 |
Why?
|
RGS Proteins | 1 | 2015 | 76 | 0.130 |
Why?
|
Dogs | 3 | 2017 | 3845 | 0.130 |
Why?
|
Binding, Competitive | 1 | 2017 | 1142 | 0.130 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1629 | 0.130 |
Why?
|
Nucleotidyltransferases | 1 | 2017 | 242 | 0.120 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 251 | 0.120 |
Why?
|
Molecular Dynamics Simulation | 2 | 2016 | 427 | 0.120 |
Why?
|
Macrolides | 1 | 2016 | 205 | 0.120 |
Why?
|
Quinolines | 1 | 2020 | 772 | 0.120 |
Why?
|
Heterocyclic Compounds | 1 | 2016 | 245 | 0.120 |
Why?
|
Cattle | 2 | 2011 | 3820 | 0.120 |
Why?
|
Ligands | 2 | 2022 | 3283 | 0.120 |
Why?
|
Biological Availability | 1 | 2015 | 392 | 0.120 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2023 | 1616 | 0.120 |
Why?
|
Protein Array Analysis | 1 | 2016 | 400 | 0.120 |
Why?
|
Catalysis | 1 | 2016 | 768 | 0.120 |
Why?
|
Drug Repositioning | 1 | 2017 | 245 | 0.120 |
Why?
|
Protein Structure, Tertiary | 3 | 2017 | 3775 | 0.120 |
Why?
|
Arthritis, Experimental | 1 | 2016 | 293 | 0.120 |
Why?
|
Sulfonamides | 2 | 2017 | 1982 | 0.110 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5892 | 0.110 |
Why?
|
Peptides, Cyclic | 1 | 2016 | 391 | 0.110 |
Why?
|
Neoplasms | 1 | 2023 | 22390 | 0.110 |
Why?
|
Maleimides | 1 | 2014 | 112 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2014 | 29 | 0.110 |
Why?
|
Morpholines | 1 | 2017 | 584 | 0.110 |
Why?
|
Antibodies | 3 | 2017 | 2422 | 0.110 |
Why?
|
Aldehydes | 1 | 2015 | 170 | 0.110 |
Why?
|
Benzothiazoles | 1 | 2015 | 248 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2008 | 3782 | 0.110 |
Why?
|
Ketones | 1 | 2015 | 183 | 0.110 |
Why?
|
Cricetulus | 1 | 2015 | 813 | 0.110 |
Why?
|
Haptens | 1 | 2013 | 163 | 0.110 |
Why?
|
Drug Resistance, Viral | 2 | 2009 | 869 | 0.110 |
Why?
|
Static Electricity | 1 | 2014 | 261 | 0.110 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2015 | 414 | 0.110 |
Why?
|
Mutation | 6 | 2024 | 30266 | 0.110 |
Why?
|
Thiazolidinediones | 1 | 2016 | 461 | 0.110 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 446 | 0.110 |
Why?
|
CHO Cells | 1 | 2015 | 1380 | 0.100 |
Why?
|
Electrons | 1 | 2014 | 264 | 0.100 |
Why?
|
Gene Library | 1 | 2015 | 1062 | 0.100 |
Why?
|
Interferons | 1 | 2016 | 720 | 0.100 |
Why?
|
Half-Life | 2 | 2017 | 651 | 0.100 |
Why?
|
Anemia, Sickle Cell | 1 | 2020 | 1065 | 0.100 |
Why?
|
Disulfides | 1 | 2014 | 467 | 0.100 |
Why?
|
Protein Conformation | 3 | 2021 | 3956 | 0.100 |
Why?
|
Phenotype | 3 | 2021 | 16735 | 0.100 |
Why?
|
Azides | 1 | 2012 | 120 | 0.100 |
Why?
|
Molecular Biology | 1 | 2015 | 573 | 0.100 |
Why?
|
Rats | 5 | 2017 | 23847 | 0.100 |
Why?
|
Histone Deacetylases | 1 | 2016 | 718 | 0.100 |
Why?
|
Immune System | 1 | 2017 | 800 | 0.100 |
Why?
|
Pharmacokinetics | 1 | 2011 | 86 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2016 | 778 | 0.090 |
Why?
|
Phenylpropanolamine | 1 | 2010 | 15 | 0.090 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 822 | 0.090 |
Why?
|
Cresols | 1 | 2010 | 26 | 0.090 |
Why?
|
Cell Cycle | 1 | 2019 | 2937 | 0.090 |
Why?
|
Peptides | 1 | 2023 | 4353 | 0.090 |
Why?
|
Cyclobutanes | 1 | 2011 | 57 | 0.090 |
Why?
|
Caco-2 Cells | 1 | 2011 | 365 | 0.090 |
Why?
|
Hydrogen Bonding | 1 | 2011 | 290 | 0.090 |
Why?
|
Oximes | 1 | 2012 | 303 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2016 | 4356 | 0.090 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 692 | 0.090 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2021 | 1473 | 0.090 |
Why?
|
Interleukin-17 | 1 | 2016 | 925 | 0.090 |
Why?
|
Titrimetry | 1 | 2009 | 36 | 0.090 |
Why?
|
Calorimetry | 1 | 2009 | 132 | 0.080 |
Why?
|
Apolipoproteins B | 1 | 2011 | 386 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2015 | 1246 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2277 | 0.080 |
Why?
|
Luciferases | 1 | 2011 | 713 | 0.080 |
Why?
|
Ulcer | 1 | 2011 | 203 | 0.080 |
Why?
|
Histamine H2 Antagonists | 1 | 2011 | 169 | 0.080 |
Why?
|
Viral Nonstructural Proteins | 1 | 2011 | 228 | 0.080 |
Why?
|
Chelating Agents | 1 | 2011 | 385 | 0.080 |
Why?
|
Benzene | 1 | 2009 | 106 | 0.080 |
Why?
|
Oligopeptides | 1 | 2015 | 1194 | 0.080 |
Why?
|
Cross-Linking Reagents | 1 | 2012 | 692 | 0.080 |
Why?
|
Oligonucleotides, Antisense | 1 | 2011 | 461 | 0.080 |
Why?
|
Piperidines | 1 | 2017 | 1669 | 0.080 |
Why?
|
Peer Review, Research | 1 | 2012 | 344 | 0.080 |
Why?
|
Drug Stability | 1 | 2009 | 292 | 0.080 |
Why?
|
Nicotine | 1 | 2013 | 681 | 0.080 |
Why?
|
Allosteric Site | 1 | 2008 | 105 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1891 | 0.080 |
Why?
|
Alkynes | 1 | 2009 | 327 | 0.070 |
Why?
|
Solutions | 1 | 2008 | 410 | 0.070 |
Why?
|
Chromatography, Thin Layer | 1 | 2007 | 212 | 0.070 |
Why?
|
Antigens | 1 | 2013 | 1444 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2023 | 5342 | 0.070 |
Why?
|
Molecular Mimicry | 2 | 2013 | 213 | 0.070 |
Why?
|
Recombinant Proteins | 2 | 2016 | 6512 | 0.070 |
Why?
|
Cyclopropanes | 1 | 2009 | 437 | 0.070 |
Why?
|
Benzoxazines | 1 | 2009 | 321 | 0.070 |
Why?
|
Nucleosides | 1 | 2007 | 131 | 0.070 |
Why?
|
Mice | 9 | 2024 | 82074 | 0.070 |
Why?
|
Cell Survival | 1 | 2016 | 5794 | 0.070 |
Why?
|
NF-kappa B | 1 | 2015 | 2492 | 0.070 |
Why?
|
RNA Interference | 1 | 2015 | 2835 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2222 | 0.060 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2006 | 139 | 0.060 |
Why?
|
Pyridines | 1 | 2017 | 2896 | 0.060 |
Why?
|
Aziridines | 1 | 2005 | 23 | 0.060 |
Why?
|
Trachea | 1 | 2011 | 1095 | 0.060 |
Why?
|
Gene Silencing | 1 | 2011 | 1505 | 0.060 |
Why?
|
Kinetics | 2 | 2014 | 6334 | 0.060 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1133 | 0.060 |
Why?
|
Vaccines | 1 | 2013 | 842 | 0.060 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2006 | 193 | 0.060 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2024 | 46 | 0.060 |
Why?
|
Benzhydryl Compounds | 1 | 2010 | 943 | 0.060 |
Why?
|
Neprilysin | 1 | 2006 | 487 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18366 | 0.050 |
Why?
|
Amines | 1 | 2005 | 280 | 0.050 |
Why?
|
Muscle Hypotonia | 1 | 2024 | 166 | 0.050 |
Why?
|
Language Development Disorders | 1 | 2024 | 193 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2006 | 752 | 0.050 |
Why?
|
Lipid A | 1 | 2002 | 70 | 0.050 |
Why?
|
Creatine | 1 | 2024 | 427 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3433 | 0.050 |
Why?
|
HIV | 1 | 2009 | 1596 | 0.050 |
Why?
|
Voltage-Dependent Anion Channel 1 | 1 | 2021 | 35 | 0.050 |
Why?
|
Diazomethane | 1 | 2021 | 37 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13427 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2021 | 2488 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6320 | 0.040 |
Why?
|
Models, Biological | 1 | 2017 | 9499 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17629 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2016 | 3588 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2024 | 1039 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3463 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11934 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7472 | 0.040 |
Why?
|
Sulfoxides | 1 | 2017 | 47 | 0.040 |
Why?
|
Escherichia coli | 2 | 2016 | 4212 | 0.040 |
Why?
|
Hepatocytes | 2 | 2017 | 1246 | 0.040 |
Why?
|
Thiadiazoles | 1 | 2017 | 63 | 0.040 |
Why?
|
Fluorescence Polarization | 1 | 2017 | 139 | 0.040 |
Why?
|
Oxidation-Reduction | 2 | 2016 | 2226 | 0.030 |
Why?
|
Nucleotides, Cyclic | 1 | 2017 | 83 | 0.030 |
Why?
|
Substrate Specificity | 2 | 2014 | 1751 | 0.030 |
Why?
|
Janus Kinase 1 | 1 | 2016 | 108 | 0.030 |
Why?
|
Trinucleotide Repeats | 1 | 2017 | 257 | 0.030 |
Why?
|
Macrocyclic Compounds | 1 | 2016 | 67 | 0.030 |
Why?
|
RNA Precursors | 1 | 2017 | 196 | 0.030 |
Why?
|
Photochemical Processes | 1 | 2016 | 85 | 0.030 |
Why?
|
Haemophilus influenzae | 1 | 2016 | 177 | 0.030 |
Why?
|
Virus Replication | 2 | 2016 | 2458 | 0.030 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2017 | 254 | 0.030 |
Why?
|
Gram-Positive Bacteria | 1 | 2016 | 178 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 515 | 0.030 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2016 | 173 | 0.030 |
Why?
|
Rhinovirus | 1 | 2016 | 209 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2017 | 719 | 0.030 |
Why?
|
Gram-Negative Bacteria | 1 | 2016 | 274 | 0.030 |
Why?
|
GRB2 Adaptor Protein | 1 | 2014 | 101 | 0.030 |
Why?
|
Signal Transduction | 2 | 2015 | 23652 | 0.030 |
Why?
|
Activating Transcription Factor 2 | 1 | 2014 | 44 | 0.030 |
Why?
|
Interferon-beta | 1 | 2016 | 349 | 0.030 |
Why?
|
Diphtheria Toxoid | 1 | 2013 | 25 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2012 | 5375 | 0.030 |
Why?
|
Aluminum Hydroxide | 1 | 2013 | 55 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2013 | 6232 | 0.030 |
Why?
|
HIV-1 | 1 | 2011 | 6963 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1056 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2016 | 705 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1608 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2013 | 253 | 0.030 |
Why?
|
RNA Splicing | 1 | 2017 | 905 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2017 | 2231 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2015 | 640 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2015 | 594 | 0.030 |
Why?
|
Bronchi | 1 | 2016 | 850 | 0.020 |
Why?
|
Somatostatin | 1 | 2014 | 458 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2017 | 1105 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2013 | 706 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2016 | 1081 | 0.020 |
Why?
|
Keratinocytes | 1 | 2016 | 876 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2024 | 4415 | 0.020 |
Why?
|
Replicon | 1 | 2011 | 35 | 0.020 |
Why?
|
Th1 Cells | 1 | 2016 | 1042 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2013 | 1065 | 0.020 |
Why?
|
Exons | 1 | 2017 | 2395 | 0.020 |
Why?
|
Erythrocytes | 1 | 2020 | 2421 | 0.020 |
Why?
|
HeLa Cells | 1 | 2017 | 3076 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2016 | 1184 | 0.020 |
Why?
|
Species Specificity | 1 | 2015 | 2419 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2016 | 1027 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3814 | 0.020 |
Why?
|
Vaccination | 1 | 2002 | 3436 | 0.020 |
Why?
|
Th17 Cells | 1 | 2016 | 791 | 0.020 |
Why?
|
Protein Engineering | 1 | 2013 | 553 | 0.020 |
Why?
|
Carbamates | 1 | 2011 | 192 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21187 | 0.020 |
Why?
|
Valine | 1 | 2011 | 410 | 0.020 |
Why?
|
Chemical Phenomena | 1 | 2009 | 486 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2017 | 14485 | 0.020 |
Why?
|
Pyrrolidines | 1 | 2011 | 342 | 0.020 |
Why?
|
Oxygen | 1 | 2020 | 4273 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 2016 | 1276 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5803 | 0.020 |
Why?
|
Cell Membrane | 1 | 2017 | 3659 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2013 | 999 | 0.020 |
Why?
|
Gene Targeting | 1 | 2011 | 841 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 17174 | 0.020 |
Why?
|
Solubility | 1 | 2009 | 1087 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2011 | 2299 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1494 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5905 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2016 | 3233 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5801 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2011 | 2067 | 0.020 |
Why?
|
Immunoconjugates | 1 | 2013 | 976 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1973 | 0.020 |
Why?
|
HIV Infections | 1 | 2011 | 17589 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2016 | 3701 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2009 | 1104 | 0.010 |
Why?
|
Hepacivirus | 1 | 2011 | 1344 | 0.010 |
Why?
|
Solvents | 1 | 2005 | 298 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2021 | 11684 | 0.010 |
Why?
|
Hydrazines | 1 | 2005 | 223 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12174 | 0.010 |
Why?
|
Water | 1 | 2009 | 1421 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8317 | 0.010 |
Why?
|
Pain | 1 | 2017 | 5100 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5800 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10486 | 0.010 |
Why?
|
Computational Biology | 1 | 2013 | 3562 | 0.010 |
Why?
|
Rabbits | 1 | 2006 | 4774 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9564 | 0.010 |
Why?
|
Asthma | 1 | 2016 | 6293 | 0.010 |
Why?
|
Smoking | 1 | 2013 | 9094 | 0.010 |
Why?
|
Swine | 1 | 2006 | 5998 | 0.010 |
Why?
|
Kidney | 1 | 2011 | 7057 | 0.010 |
Why?
|
Liver | 1 | 2011 | 7579 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 14199 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 8200 | 0.010 |
Why?
|
Female | 4 | 2017 | 397464 | 0.010 |
Why?
|
Male | 3 | 2017 | 365249 | 0.010 |
Why?
|